/mis/ajx
Veröffentlichung der Original-Studie: 09.01.2024 / 05:49 / GMT
Erstmalige Weitergabe der Original-Studie: 09.01.2024 / 05:50 / GMT
Hinweis: Informationen zur Offenlegungspflicht bei Interessenkonflikten im Sinne von § 85 Abs. 1 WpHG, Art. 20 VO (EU) 596/2014 für das genannte Analysten-Haus finden Sie unter http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
Insiders
Im Artikel erwähnte Wertpapiere
Zu einer Liste hinzufügen 0 ausgewählt |
Kurs
|
%
|
% 5 Tage
|
Kap.
| |
---|---|---|---|---|---|
29,1 EUR | +1,64 % | +3,82 % | 17,43 Mrd. | ||
Michael Sen is currently the Chief Executive Officer at Fresenius SE & Co. KGaA, Fresenius Management SE, and the Chairman-Supervisory Board at Fresenius Medical Care AG, Fresenius Medical Care Management AG, and Fresenius Kabi AG.
He previously held the position of Chief Financial Officer at Siemens Healthcare Services Ltd.
Mr. Sen's former positions include Chief Executive Officer-Power & Gas at Siemens AG, Executive Chairman-Supervisory Board at Siemens Healthineers AG, Director at Siemens Gamesa Renewable Energy SA, Chief Financial Officer at E.ON SE, Member-Management Board at Siemens Ltd.
China, Member-Management Board at Siemens Ltd.
(South Korea), Member-Management Board at Siemens Healthcare KK, Member-Management Board at Siemens Japan Holding KK, and Member-Supervisory Board at Uniper SE.
He obtained an MBA from the Technical University of Berlin in 1991.
Größte Unternehmen | |
---|---|
Siemens Healthcare Services Ltd.
Siemens Healthcare Services Ltd. Life/Health InsuranceFinance Siemens Healthcare Services Ltd. provides accident and health insurance services. The company is headquartered in Bracknell, the United Kingdom. | Finanzdirektor/CFO |
FRESENIUS SE & CO. KGAA | Vorstandsvorsitzender |
Aktuelle Nachrichten zu Michael Sen
- Börse
- Insiders
- Michael Sen
- JPMorgan belässt Fresenius SE auf 'Neutral' - Ziel 32,50 Euro